|
C12ORF5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.128600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.055400E-01 |
| Normal-vs-Stage2 |
9.676200E-01 |
| Normal-vs-Stage3 |
4.406600E-01 |
| Normal-vs-Stage4 |
9.783800E-01 |
| Stage1-vs-Stage2 |
7.260200E-01 |
| Stage1-vs-Stage3 |
4.969000E-01 |
| Stage1-vs-Stage4 |
7.591200E-01 |
| Stage2-vs-Stage3 |
4.493000E-01 |
| Stage2-vs-Stage4 |
9.919000E-01 |
| Stage3-vs-Stage4 |
5.128800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.337600E-01 |
| Normal-vs-AfricanAmerican |
1.260600E-01 |
| Normal-vs-Asian |
8.743400E-01 |
| Caucasian-vs-AfricanAmerican |
8.323900E-02 |
| Caucasian-vs-Asian |
8.117800E-01 |
| AfricanAmerican-vs-Asian |
3.571600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.273000E-01 |
| Normal-vs-Female |
5.433600E-01 |
| Male-vs-Female |
5.845000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.249400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.609200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.441200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.310600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.273000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.416800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.462600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.551600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.058600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.240800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.480800E-01 |
| Normal-vs-Grade 2 |
9.108400E-01 |
| Normal-vs-Grade 3 |
3.051200E-01 |
| Normal-vs-Grade 4 |
9.411400E-01 |
| Grade 1-vs-Grade 2 |
6.634400E-01 |
| Grade 1-vs-Grade 3 |
4.390600E-01 |
| Grade 1-vs-Grade 4 |
6.265400E-01 |
| Grade 2-vs-Grade 3 |
9.918300E-02 |
| Grade 2-vs-Grade 4 |
8.683600E-01 |
| Grade 3-vs-Grade 4 |
5.320800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.956200E-01 |
| Normal-vs-ccB subtype |
8.937200E-01 |
| ccA subtype-vs-ccB subtype |
1.000000E+00 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.358600E-01 |
| Normal-vs-N1 |
7.716000E-01 |
| N0-vs-N1 |
7.878000E-01 |
|
|
